Vagus Nerve Stimulation (VNS) Therapy for Major Depressive Disorder and Treatment-Resistant Depression
At our clinic, we are committed to offering innovative and evidence-based treatment options for individuals struggling with Major Depressive Disorder (MDD), as well as those facing the challenges of treatment-resistant depression (TRD) and Bipolar Disorder I or II. Among the advanced therapies available is Vagus Nerve Stimulation (VNS), an FDA approved, neuromodulation treatment that can offer new hope for individuals who have not found relief through traditional methods such as medication, psychotherapy, or electroconvulsive therapy (ECT).
What is VNS Therapy?
Vagus Nerve Stimulation is a long-term treatment that involves the surgical implantation of a small device, similar to a pacemaker, typically placed under the skin in the chest. This device is connected to the vagus nerve in the neck and delivers mild, regular electrical pulses that travel to the brain. These pulses are designed to modulate activity in areas of the brain that affect mood regulation, emotional processing, and mental well-being.
Over time, VNS therapy can lead to sustained improvement in depressive symptoms, particularly in individuals who have not responded adequately to multiple antidepressant treatments. It is not a quick fix, but many patients experience gradual and meaningful relief, often accompanied by improved quality of life and functioning.
Who May Benefit from VNS?
VNS therapy may be appropriate for adults who:
Have been diagnosed with Major Depressive Disorder, Treatment-Resistant Depression (TRD) and Bipolar Disorder I or II.
Have tried and not responded to multiple standard treatments (medications and/or psychotherapy)
Continue to experience significant symptoms despite comprehensive treatment efforts
Each patient undergoes a thorough evaluation to determine if VNS is a suitable option based on clinical history, current symptoms, and overall health.
Accessing VNS Therapy at Our Clinic
We offer access to VNS therapy through two pathways:
Participation in a Clinical Study; Qualified individuals may receive VNS as part of an ongoing clinical trial. These studies aim to further explore the effectiveness and long-term benefits of VNS therapy under close clinical supervision.
Commercially Available Treatment; For patients who meet criteria and prefer a standard clinical setting, VNS therapy is also available as an FDA-approved treatment for treatment-resistant depression.
Our team will guide you through the assessment and decision-making process, helping you understand your options and choose the approach that best aligns with your goals and preferences.